GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial shift in how we handle type 2 diabetes . These new medications work by stimulating the body’s inherent GLP-1 process, https://guidemysocial.com/story7202031/glp-1-a-revolutionary-breakthrough-in-blood-sugar-care